ILMN’s TSO Comprehensive IVD Test Secures FDA Approval as CDx
ZacksIllumina’s cancer biomarker test, TSO Comprehensive, gets approved by the FDA for use as CDx to match patients with targeted therapies.
Illumina’s cancer biomarker test, TSO Comprehensive, gets approved by the FDA for use as CDx to match patients with targeted therapies.